Spinogenix
Clinical trials sponsored by Spinogenix, explained in plain language.
-
ALS drug trial extended to check Long-Term safety
Disease control TerminatedThis study aimed to check the long-term safety of an oral medication called SPG302 for people with ALS (Lou Gehrig's disease). It was an extension of an earlier trial, allowing 16 participants to continue taking the drug for up to one year. The main goal was to monitor side effec…
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Alzheimer's drug extension study halted after 12 patients
Disease control TerminatedThis study aimed to test the long-term safety and effectiveness of an oral medication called SPG302 for people with mild-to-moderate Alzheimer's disease. It was an extension of a previous trial, allowing participants to continue taking the drug for up to one year while monitoring…
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC